Biotech Startup M&A Is Reliably Delivering Some Big Exits

Over the past two calendar years, acquirers have agreed to pay more than $38 billion to purchase venture-backed companies in Crunchbase biotech industry categories. So far, 2026 is off to a brisk start as well.